skip to content
  1. Home
  2. >
  3. Questions
  4. >
  5. GUD: Your thoughts please on the quarter? [Knight Therapeutics Inc.]
You can view 0 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Your thoughts please on the quarter? If waiting for the cc I can wait for your response


Thx
Asked by blake on May 07, 2026
5i Research Answer:

EPS of $0.13 beat estimates of $0.015 and sales of $147.59M beat estimates of $113.32M. Sales grew 69%, and its Adjusted EBITDA of $27.9M more than doubled year-over-year. Margins expanded in the quarter, and management raised 2026 sales guidance from a $490M to $510M range to $510M to $525M, with adjusted EBITDA of about 15% of sales. We think investors should be pleased with these results.